EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism
Authors:
- Joaquin Olmedo-PelayoJOJoaquin Olmedo-Pelayo
- Esperanza Granado-CalleEGEsperanza Granado-Calle
- Daniel Delgado-BellidoDDDaniel Delgado-Bellido
- Laura Lobo-SelmaLLLaura Lobo-Selma
- Ana T. Monteiro-AmaralAMAna T. Monteiro-Amaral
- Shunya OhmuraSOShunya Ohmura
- Angel M. CarcabosoACAngel M. Carcaboso
- Javier AlonsoJAJavier Alonso
- Antonio Llombart-BoschAntonio Llombart-Bosch
Preprint
Abstract
Drug resistance is one of the major factors associated with poor outcome of cancer patients. Treatment of Ewing sarcoma (EwS), an aggressive neoplasm mainly affecting children, adolescents and young adults, is associated with therapy failure and tumor relapse in 30-80% of the cases. Thus, it supports the need to explore the mechanisms modulating drug activity. Here, we describe a novel mechanism of drug sensitivity based on the role of EWS::FLI1 in R-loop metabolism. Our results demonstrate that EWS::FLI1 promotes R-loop formation favoring the interaction between DHX9 and elongating RNA polymerase II. In addition, we discovered that EWS::FLI1 kidnaps DHX9 preventing the resolution of TOP1 poisoning-associated R-loops. Our findings indicate that R-loops accumulation promotes replicative stress, genome instability and cell sensitivity to SN-38. Collectively, these results uncover a novel mechanism behind EwS sensitivity to genotoxic agents, with relevant implications for EwS treatment.Keywords
All Related Versions
- Published version: Oncogene, 44 (38), 1.
This publication has 48 references indexed in Scilit:
- Lysyl Oxidase Is Downregulated by the EWS/FLI1 Oncoprotein and Its Propeptide Domain Displays Tumor Supressor Activities in Ewing Sarcoma CellsPLOS ONE, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- RNase H and Multiple RNA Biogenesis Factors Cooperate to Prevent RNA:DNA Hybrids from Generating Genome InstabilityMolecular Cell, 2011
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcomaNature Medicine, 2009
- ATR: an essential regulator of genome integrityNature Reviews Molecular Cell Biology, 2008
- Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 DecadesJournal of Pediatric Hematology/Oncology, 2008
- Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor GrowthClinical Cancer Research, 2007
- Oncoprotein EWS-FLI1 Activity Is Enhanced by RNA Helicase ACancer Research, 2006
- Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumoursNature, 1992
- The S-phase cytotoxicity of camptothecinExperimental Cell Research, 1991